Post-transplant Cyclophosphamide is a Valid Option for GVHD Prophylaxis in Both HLA-matched and Mismatched Allogeneic Transplants
Nahla A. M. Hamed, Dalia A. Nafea, Essam A. Abdel-Mohsen, Omar M. Ghalab & Abdel-Salam A. Adam · Asian Hematology Research Journal · 2019
Despite improvement in transplantation techniques and supportive care, graft versus host disease (GVHD) remains a major cause of post-transplant morbidity and mortality. Advances in immunosuppressive regimens have reduced the incidence and severity of acute GVHD; with no such imp...
Open access
Research Article